Cargando…

A novel One-pot rapid diagnostic technology for COVID-19

Novel coronavirus disease (COVID-19) caused by SARS-CoV-2 is an ongoing global pandemic associated with high rates of morbidity and mortality. RT-qPCR has become the diagnostic standard for the testing of SARS-CoV-2 in most countries. COVID-19 diagnosis generally relies upon RT-qPCR-mediated identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junmin, Hu, Xuejiao, Wang, Xiaoming, Yang, Jianing, Zhang, Lei, Deng, Qianyun, Zhang, Xiqin, Wang, Zixia, Hou, Tieying, Li, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877206/
https://www.ncbi.nlm.nih.gov/pubmed/33736798
http://dx.doi.org/10.1016/j.aca.2021.338310
_version_ 1783650121343303680
author Li, Junmin
Hu, Xuejiao
Wang, Xiaoming
Yang, Jianing
Zhang, Lei
Deng, Qianyun
Zhang, Xiqin
Wang, Zixia
Hou, Tieying
Li, Shan
author_facet Li, Junmin
Hu, Xuejiao
Wang, Xiaoming
Yang, Jianing
Zhang, Lei
Deng, Qianyun
Zhang, Xiqin
Wang, Zixia
Hou, Tieying
Li, Shan
author_sort Li, Junmin
collection PubMed
description Novel coronavirus disease (COVID-19) caused by SARS-CoV-2 is an ongoing global pandemic associated with high rates of morbidity and mortality. RT-qPCR has become the diagnostic standard for the testing of SARS-CoV-2 in most countries. COVID-19 diagnosis generally relies upon RT-qPCR-mediated identification of SARS-CoV-2 viral RNA, which is costly, labor-extensive, and requires specialized training and equipment. Herein, we established a novel one-tube rapid diagnostic approach based upon formamide and colorimetric RT-LAMP (One-Pot RT-LAMP) that can be used to diagnose COVID-19 without the extraction of specific viral RNA. The technique could visually detect SARS-CoV-2 within 45 min with a limit of detection of 5 copies per reaction in extracted RNA, and about 7.66 virus copies per μL in viral transport medium. The One-Pot RT-LAMP test showed a high specificity without cross-reactivity with 12 viruses including SARS-CoV, MERS-CoV, and human infectious influenza virus (H1N1/H3N2 of influenza A and B virus, ect. We validated this One-Pot RT-LAMP approach by its successful use for the analysis of 45 clinical nasopharyngeal swab samples, yielding results identical to those of traditional RT-qPCR analyses, while achieving good selectivity and sensitivity relative to a commercial RT-qPCR approach. As such, this One-Pot RT-LAMP technology may be a valid means of conducting high-sensitivity, low-cost and rapid SARS-CoV-2 identification without the extraction of viral RNA.
format Online
Article
Text
id pubmed-7877206
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-78772062021-02-11 A novel One-pot rapid diagnostic technology for COVID-19 Li, Junmin Hu, Xuejiao Wang, Xiaoming Yang, Jianing Zhang, Lei Deng, Qianyun Zhang, Xiqin Wang, Zixia Hou, Tieying Li, Shan Anal Chim Acta Article Novel coronavirus disease (COVID-19) caused by SARS-CoV-2 is an ongoing global pandemic associated with high rates of morbidity and mortality. RT-qPCR has become the diagnostic standard for the testing of SARS-CoV-2 in most countries. COVID-19 diagnosis generally relies upon RT-qPCR-mediated identification of SARS-CoV-2 viral RNA, which is costly, labor-extensive, and requires specialized training and equipment. Herein, we established a novel one-tube rapid diagnostic approach based upon formamide and colorimetric RT-LAMP (One-Pot RT-LAMP) that can be used to diagnose COVID-19 without the extraction of specific viral RNA. The technique could visually detect SARS-CoV-2 within 45 min with a limit of detection of 5 copies per reaction in extracted RNA, and about 7.66 virus copies per μL in viral transport medium. The One-Pot RT-LAMP test showed a high specificity without cross-reactivity with 12 viruses including SARS-CoV, MERS-CoV, and human infectious influenza virus (H1N1/H3N2 of influenza A and B virus, ect. We validated this One-Pot RT-LAMP approach by its successful use for the analysis of 45 clinical nasopharyngeal swab samples, yielding results identical to those of traditional RT-qPCR analyses, while achieving good selectivity and sensitivity relative to a commercial RT-qPCR approach. As such, this One-Pot RT-LAMP technology may be a valid means of conducting high-sensitivity, low-cost and rapid SARS-CoV-2 identification without the extraction of viral RNA. Elsevier B.V. 2021-04-15 2021-02-11 /pmc/articles/PMC7877206/ /pubmed/33736798 http://dx.doi.org/10.1016/j.aca.2021.338310 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Li, Junmin
Hu, Xuejiao
Wang, Xiaoming
Yang, Jianing
Zhang, Lei
Deng, Qianyun
Zhang, Xiqin
Wang, Zixia
Hou, Tieying
Li, Shan
A novel One-pot rapid diagnostic technology for COVID-19
title A novel One-pot rapid diagnostic technology for COVID-19
title_full A novel One-pot rapid diagnostic technology for COVID-19
title_fullStr A novel One-pot rapid diagnostic technology for COVID-19
title_full_unstemmed A novel One-pot rapid diagnostic technology for COVID-19
title_short A novel One-pot rapid diagnostic technology for COVID-19
title_sort novel one-pot rapid diagnostic technology for covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877206/
https://www.ncbi.nlm.nih.gov/pubmed/33736798
http://dx.doi.org/10.1016/j.aca.2021.338310
work_keys_str_mv AT lijunmin anovelonepotrapiddiagnostictechnologyforcovid19
AT huxuejiao anovelonepotrapiddiagnostictechnologyforcovid19
AT wangxiaoming anovelonepotrapiddiagnostictechnologyforcovid19
AT yangjianing anovelonepotrapiddiagnostictechnologyforcovid19
AT zhanglei anovelonepotrapiddiagnostictechnologyforcovid19
AT dengqianyun anovelonepotrapiddiagnostictechnologyforcovid19
AT zhangxiqin anovelonepotrapiddiagnostictechnologyforcovid19
AT wangzixia anovelonepotrapiddiagnostictechnologyforcovid19
AT houtieying anovelonepotrapiddiagnostictechnologyforcovid19
AT lishan anovelonepotrapiddiagnostictechnologyforcovid19
AT lijunmin novelonepotrapiddiagnostictechnologyforcovid19
AT huxuejiao novelonepotrapiddiagnostictechnologyforcovid19
AT wangxiaoming novelonepotrapiddiagnostictechnologyforcovid19
AT yangjianing novelonepotrapiddiagnostictechnologyforcovid19
AT zhanglei novelonepotrapiddiagnostictechnologyforcovid19
AT dengqianyun novelonepotrapiddiagnostictechnologyforcovid19
AT zhangxiqin novelonepotrapiddiagnostictechnologyforcovid19
AT wangzixia novelonepotrapiddiagnostictechnologyforcovid19
AT houtieying novelonepotrapiddiagnostictechnologyforcovid19
AT lishan novelonepotrapiddiagnostictechnologyforcovid19